BOSTON–(BUSINESS WIRE)–Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), announced today that it will be added to the Russell US Index Series in conjunction with the September 2022 quarterly review, effective after the US market open on Monday, September 19, 2022. Russell indexes are widely … [Read more…]
TORONTO–(BUSINESS WIRE)–Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), today announced its second quarter 2022 (“Q2 2022”) operational and financial results. All values in this press release are in United States dollars, unless otherwise stated. SECOND QUARTER 2022 OPERATIONAL AND FINANCIAL HIGHLIGHTS Revenue for Q2 2022 increased by 4% to a record … [Read more…]
MedX Announces Tarek El Hoss as Sr. Vice President, Market Development and Sales MISSISSAUGA, Ontario–(BUSINESS WIRE)–$MDX #SkinCancer–MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX), a global leader in teledermatology, is pleased to announce that Tarek El Hoss has been appointed as the Company’s Vice President, Market Development and Sales. Mr. El Hoss will oversee … [Read more…]
NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson (NYSE: JNJ) will participate in the 2022 Wells Fargo Securities Healthcare Conference at the Encore Boston Harbor in Everett, MA on Wednesday, September 7th. Ashley McEvoy, Executive Vice President, Worldwide Chairman, MedTech will represent the Company in a session scheduled at 11:00 a.m. (Eastern Time). This conference call will … [Read more…]
IRVINE, Calif.–(BUSINESS WIRE)–Axonics, Inc. (Nasdaq: AXNX) (“Axonics”), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced that it has commenced a proposed underwritten public offering of 1,750,000 shares of its common stock. Axonics expects to grant the underwriter a 30-day option to … [Read more…]
MENLO PARK, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that it filed a lawsuit against Foresight Diagnostics Inc. for infringement of Personalis’ U.S. Patent Nos. 10,450,611, 11,299,783, and 11,384,394. These patents are part of Personalis’ intellectual property portfolio in the field of whole genome-enabled, tumor-informed molecular residual disease … [Read more…]
CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that an article highlighting data using tris-Gold complexes to increase the chemical diversity of Bicycles, was published in Bioconjugate Chemistry. The article, titled “Gold-Mediated Multiple … [Read more…]
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced second quarter 2022 financial results. “We delivered a remarkable second quarter as we continue changing the standard of care for millions of patients globally,” said Michael … [Read more…]
Blackwell Captive Solutions to Serve Self-funded Health Plans SAN FRANCISCO–(BUSINESS WIRE)–Carrick Capital Partners, a growth-oriented investment firm focused on technology-enabled businesses, is proud to welcome industry veteran, Kari L. Niblack, as the President of Blackwell Captive Solutions, a Carrick-sponsored medical stop-loss group captive management company. Blackwell Captive Solutions will help ERISA plans reduce their expense … [Read more…]
PGA TOUR stop in Memphis benefits St. Jude Children’s Research Hospital MEMPHIS, Tenn.–(BUSINESS WIRE)–Colorful, creative images of Earth and messages of hope from around the world will make up the globally focused patient art featured during the week of the 2022 FedEx St. Jude Championship. St. Jude Children’s Research Hospital® has been the sole charitable … [Read more…]
